NCT05157061
GOS to Reduce Symptom Severity in IBS No drug interventions treatment Not Available recruiting NCT00171431
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) treatment 3 terminated NCT00584571
SAT vs Escitalopram for Rectal Hypersensitivity treatment 2 completed NCT00619125
Proposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm Pilot No drug interventions Not Available Not Available completed NCT05240521
Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C No drug interventions treatment Not Available unknown_status NCT06553547
4-Week, Multi-Center, Randomized, Db-Blind, Placebo-Controlled, Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs treatment 2 recruiting NCT03471728
Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) Not Available Not Available completed NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years treatment 3 recruiting NCT02495623
A Study of the Effect of SYN-010 on Subjects With IBS-C No drug interventions treatment 2 completed NCT02316899
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome treatment 3 completed NCT02493036
A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C No drug interventions treatment 2 completed NCT01880424
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) treatment 3 completed NCT05905926
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C health_services_research 3 enrolling_by_invitation NCT02078323
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients other Not Available completed NCT02144753
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II) supportive_care 2 terminated NCT01714843
A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome treatment 2 completed NCT01056107
Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients No drug interventions treatment 1 / 2 completed NCT02559245
Effect of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation: a Single Blind Randomized Clinical Trial. No drug interventions treatment Not Available completed NCT02727751
A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C treatment 3 completed NCT01340053
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C) No drug interventions treatment 2 completed NCT05321953
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation No drug interventions treatment Not Available withdrawn NCT05921383
Anorectal Manometry of Patients With Constipation Predominant IBS No drug interventions Not Available Not Available not_yet_recruiting NCT00607971
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) Not Available 3 terminated NCT05757037
Laser Acupuncture on Irritable Bowel Syndrome in Females No drug interventions treatment Not Available recruiting NCT03336034
Assessment of Responsiveness to Treatment by Experience Sampling Method No drug interventions Not Available Not Available terminated NCT05392439
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT01923428
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C) treatment 2 / 3 completed NCT00742872
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome treatment 3 terminated NCT03150212
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype No drug interventions treatment Not Available completed NCT05941650
To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome No drug interventions treatment Not Available not_yet_recruiting NCT01085643
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) basic_science Not Available completed NCT05134584
Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders treatment 4 unknown_status NCT05164861
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations No drug interventions treatment Not Available completed NCT02686138
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C treatment 3 completed NCT02621892
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C treatment 3 completed NCT00945334
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome treatment Not Available completed NCT06319729
A Chinese Herbal Medicine for IBS-C No drug interventions treatment 2 not_yet_recruiting NCT00912301
Cheno Effect on Transit in Health and IBS-C treatment 2 completed NCT04666155
MOWOOT Device Treatment for Adults With Chronic Constipation No drug interventions treatment Not Available not_yet_recruiting NCT03596905
Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C) treatment 2 recruiting NCT05519683
Home Transcutaneous Electrical Acustimulation (TEA) treatment 2 / 3 recruiting NCT00511771
A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation Not Available Not Available no_longer_available NCT04968652
IBS-C Questionnaire Study No drug interventions Not Available Not Available completed NCT03763175
Efficacy and Safety of SYN-010 in IBS-C treatment 2 terminated NCT04214470
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS No drug interventions Not Available Not Available unknown_status NCT00765999
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation treatment 3 completed NCT02559817
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation treatment 2 terminated NCT04166058
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C No drug interventions treatment 3 active_not_recruiting NCT04997057
A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation No drug interventions treatment Not Available completed NCT04647045
An Evaluation of Cultured Milk Drink on Immune Status of Patients With Irritable Bowel Syndrome: Constipation Predominant No drug interventions basic_science Not Available completed NCT00460811
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) treatment 2 completed NCT00730171
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation treatment 3 completed NCT05796388
A Study of Virtual Reality and Linaclotide for IBS-C No drug interventions treatment Not Available recruiting NCT06219707
Electro-acupuncture for Irritable Bowel Syndrome With Constipation No drug interventions treatment Not Available not_yet_recruiting NCT02590432
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation treatment 4 completed NCT03054506
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation No drug interventions treatment Not Available completed NCT02559206
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) treatment 2 completed NCT04026113
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) treatment 3 completed NCT00938717
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) No drug interventions treatment 3 completed NCT05646186
Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome No drug interventions treatment Not Available unknown_status NCT00215566
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c treatment 2 completed NCT04484467
Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT04132804
Effect of Tai Chi as Treatment for IBS-C No drug interventions treatment Not Available completed NCT00380250
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation treatment 3 completed